-
1
-
-
2142758687
-
HER-2 testing in breast cancer using parallel tissue-based methods
-
10.1001/jama.291.16.1972. 15113815
-
HER-2 testing in breast cancer using parallel tissue-based methods. H Yaziji LC Goldstein TS Barry R Werling H Hwang GK Ellis JR Gralow RB Livingston AM Gown, JAMA 2004 291 1972 1977 10.1001/jama.291.16.1972 15113815
-
(2004)
JAMA
, vol.291
, pp. 1972-1977
-
-
Yaziji, H.1
Goldstein, L.C.2
Barry, T.S.3
Werling, R.4
Hwang, H.5
Ellis, G.K.6
Gralow, J.R.7
Livingston, R.B.8
Gown, A.M.9
-
2
-
-
3042622482
-
HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues
-
10.3816/CBC.2004.n.011. 15140287
-
HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues. MA Owens BC Horten MM Da Silva, Clin Breast Cancer 2004 5 63 69 10.3816/CBC.2004.n.011 15140287
-
(2004)
Clin Breast Cancer
, vol.5
, pp. 63-69
-
-
Owens, M.A.1
Horten, B.C.2
Da Silva, M.M.3
-
3
-
-
33847147313
-
American society of clinical oncology/college of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
-
10.1200/JCO.2006.09.2775. 17159189
-
American society of clinical oncology/college of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. AC Wolff ME Hammond JN Schwartz KL Hagerty DC Allred RJ Cote M Dowsett PL Fitzgibbons WM Hanna A Langer LM McShane S Paik MD Pegram EA Perez MF Press A Rhodes C Sturgeon SE Taube R Tubbs GH Vance M van de Vijver TM Wheeler DF Hayes, J Clin Oncol 2007 25 118 145 10.1200/JCO.2006.09.2775 17159189
-
(2007)
J Clin Oncol
, vol.25
, pp. 118-145
-
-
Wolff, A.C.1
Hammond, M.E.2
Schwartz, J.N.3
Hagerty, K.L.4
Allred, D.C.5
Cote, R.J.6
Dowsett, M.7
Fitzgibbons, P.L.8
Hanna, W.M.9
Langer, A.10
McShane, L.M.11
Paik, S.12
Pegram, M.D.13
Perez, E.A.14
Press, M.F.15
Rhodes, A.16
Sturgeon, C.17
Taube, S.E.18
Tubbs, R.19
Vance, G.H.20
De Van, V.M.21
Wheeler, T.M.22
Hayes, D.F.23
more..
-
4
-
-
34547095237
-
Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-postive breast cancer
-
10.1002/cncr.22806. 17592827
-
Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-postive breast cancer. LP Garrison Jr D Lubeck D Lalla V Paton A Dueck EA Perez, Cancer 2007 110 489 498 10.1002/cncr.22806 17592827
-
(2007)
Cancer
, vol.110
, pp. 489-498
-
-
Garrison Jr., L.P.1
Lubeck, D.2
Lalla, D.3
Paton, V.4
Dueck, A.5
Perez, E.A.6
-
5
-
-
33847038462
-
Trastuzumab in adjuvant breast cancer therapy. a model based cost-effectivemess analysis
-
10.1080/02841860601096841. 17453363
-
Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectivemess analysis. J Norum JA Olsen EA Wist PE Lønning, Acta Oncol 2007 46 153 164 10.1080/02841860601096841 17453363
-
(2007)
Acta Oncol
, vol.46
, pp. 153-164
-
-
Norum, J.1
Olsen, J.A.2
Wist, E.A.3
Lønning, P.E.4
-
6
-
-
34548674957
-
Cost/effectiveness analysis of adjuvant therapy with trastuzumab in patients with HER2 positive early breast cancer
-
17723955
-
Cost/effectiveness analysis of adjuvant therapy with trastuzumab in patients with HER2 positive early breast cancer. F Fagnani X Colin P Arveux B Coudert JL Misset, Bull Cancer 2007 94 711 720 17723955
-
(2007)
Bull Cancer
, vol.94
, pp. 711-720
-
-
Fagnani, F.1
Colin, X.2
Arveux, P.3
Coudert, B.4
Misset, J.L.5
-
7
-
-
34248376048
-
Cost effectiveness of trastuzumab in the early breast cancer: A lifetime model
-
10.2165/00019053-200725050-00006
-
Cost effectiveness of trastuzumab in the early breast cancer: a lifetime model. JA Millar MJ Millward, Pharmocoeconomics 2007 25 429 442 10.2165/00019053-200725050-00006
-
(2007)
Pharmocoeconomics
, vol.25
, pp. 429-442
-
-
Millar, J.A.1
Millward, M.J.2
-
8
-
-
34548481766
-
111Indium-trastuzumab visualizes myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: A clue to uncover the mechanisms of trastuzumab-related cardiotoxicity
-
10.1016/j.ejca.2007.06.024. 17719768
-
111Indium-trastuzumab visualizes myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: a clue to uncover the mechanisms of trastuzumab-related cardiotoxicity. MA de Korte EG de Vries MN Lub-de Hooge PL Jager JA Gietema WT van der Graaf WJ Sluiter DJ van Veldhuisen TM Suter DT Sleijfer PJ Perik, Eur J Cancer 2007 43 2046 2051 10.1016/j.ejca.2007.06.024 17719768
-
(2007)
Eur J Cancer
, vol.43
, pp. 2046-2051
-
-
De Korte, M.A.1
De Vries, E.G.2
Lub-De Hooge, M.N.3
Jager, P.L.4
Gietema, J.A.5
Der Van Graff, W.T.6
Sluiter, W.J.7
Van Veldhuisen, D.J.8
Suter, T.M.9
Sleijfer, D.T.10
Perik, P.J.11
-
9
-
-
33750457624
-
Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer
-
10.1158/1535-7163.MCT-06-0129. 17041102
-
Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer. L Dal Lago V Durbecq C Desmedt R Salgado T Verjat L Lespagnard Y Ma I Veys A Di Leo C Sotiriou M Piccart D Larsimont, Mol Cancer Ther 2006 5 2572 2579 10.1158/1535-7163.MCT-06- 0129 17041102
-
(2006)
Mol Cancer Ther
, vol.5
, pp. 2572-2579
-
-
Dal Lago, L.1
Durbecq, V.2
Desmedt, C.3
Salgado, R.4
Verjat, T.5
Lespagnard, L.6
Ma, Y.7
Veys, I.8
Di Leo, A.9
Sotiriou, C.10
Piccart, M.11
Larsimont, D.12
-
10
-
-
33644508444
-
Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: A study of 175 cases using fluorescence in situ hybridization and immunohistochemistry
-
15743507. 10.1186/bcr996
-
Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry. M Salido I Tusquets JM Corominas M Suarez B Espinet C Corzo M Bellet X Fabregat S Serrano F Solé Breast Cancer Res 2005 7 R267 R273 15743507 10.1186/bcr996
-
(2005)
Breast Cancer Res
, vol.7
-
-
Salido, M.1
Tusquets, I.2
Corominas, J.M.3
Suarez, M.4
Espinet, B.5
Corzo, C.6
Bellet, M.7
Fabregat, X.8
Serrano, S.9
Solé, F.10
-
11
-
-
35448973389
-
HER2 status in early breast cancer: Relevance of cell staining patterns, gene amplification and polysomy 17
-
10.1016/j.ejca.2007.07.033. 17855075
-
HER2 status in early breast cancer: relevance of cell staining patterns, gene amplification and polysomy 17. R Torrisi N Rotmensz V Bagnardi G Viale BD Curto P Dell'orto P Veronesi A Luini C D'Alessandro A Cardillo A Goldhirsch M Colleoni, Eur J Cancer 2007 43 2339 2344 10.1016/j.ejca.2007.07.033 17855075
-
(2007)
Eur J Cancer
, vol.43
, pp. 2339-2344
-
-
Torrisi, R.1
Rotmensz, N.2
Bagnardi, V.3
Viale, G.4
Curto, B.D.5
Dell'Orto, P.6
Veronesi, P.7
Luini, A.8
D'Alessandro, C.9
Cardillo, A.10
Goldhirsch, A.11
Colleoni, M.12
-
12
-
-
40449103809
-
Comparison of different commercial kits for HER2 testing in breast cancer: Looking for the accurate cut-off for amplification
-
17908324
-
Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cut-off for amplification. A Cayre F Mishellany N Lagarde F Penault-Llorca, Breast Cancer Res 2007 17908324
-
(2007)
Breast Cancer Res
-
-
Cayre, A.1
Mishellany, F.2
Lagarde, N.3
Penault-Llorca, F.4
-
13
-
-
33645326209
-
Unlocking pathology archives for molecular genetic studies: A realizable method to generate probes for chromogenic and fluorescent in situ hybridization
-
10.1038/labinvest.3700390. 16446704
-
Unlocking pathology archives for molecular genetic studies: a realizable method to generate probes for chromogenic and fluorescent in situ hybridization. MB Lambros PT Simpson C Jones R Natrajan C Westbury D Steele K Savage A Mackay FC Schmitt A Ashworth JS Reis-Filho, Lab Invest 2006 86 398 408 10.1038/labinvest.3700390 16446704
-
(2006)
Lab Invest
, vol.86
, pp. 398-408
-
-
Lambros, M.B.1
Simpson, P.T.2
Jones, C.3
Natrajan, R.4
Westbury, C.5
Steele, D.6
Savage, K.7
MacKay, A.8
Schmitt, F.C.9
Ashworth, A.10
Reis-Filho, J.S.11
-
14
-
-
33745986327
-
HER2 testing by local, central, and reference laboratories in specimens from the north central cancer treatment group N9831 intergroup adjuvant trial
-
10.1200/JCO.2005.03.4744. 16809727
-
HER2 testing by local, central, and reference laboratories in specimens from the north central cancer treatment group N9831 intergroup adjuvant trial. EA Perez VJ Suman NE Davidson S Martino PA Kaufman WL Lingle PJ Flynn JN Ingle D Visscher RB Jenkins, J Clin Oncol 2006 24 3032 3038 10.1200/JCO.2005.03.4744 16809727
-
(2006)
J Clin Oncol
, vol.24
, pp. 3032-3038
-
-
Perez, E.A.1
Suman, V.J.2
Davidson, N.E.3
Martino, S.4
Kaufman, P.A.5
Lingle, W.L.6
Flynn, P.J.7
Ingle, J.N.8
Visscher, D.9
Jenkins, R.B.10
-
15
-
-
34247363714
-
Standardization of HER2 testing: Results of an international proficiency-testing ring study
-
10.1038/modpathol.3800774. 17396141
-
Standardization of HER2 testing: results of an international proficiency-testing ring study. M Dowsett WM Hanna M Kockx F Penault-Llorca J Rüschoff T Gutjahr K Habben MJ van de Vijver, Mod Pathol 2007 20 584 591 10.1038/modpathol.3800774 17396141
-
(2007)
Mod Pathol
, vol.20
, pp. 584-591
-
-
Dowsett, M.1
Hanna, W.M.2
Kockx, M.3
Penault-Llorca, F.4
Rüschoff, J.5
Gutjahr, T.6
Habben, K.7
De Van Vijver, M.J.8
-
16
-
-
33644968665
-
HER-2 fluorescence in situ hybridization: Results from the survey program of the College of American Pathologists
-
16519559
-
HER-2 fluorescence in situ hybridization: results from the survey program of the College of American Pathologists. DL Persons RR Tubbs LD Cooley GW Dewald PK Dowling E Du JT Mascarello KW Rao KS Wilson DJ Wolff G Habegger-Vance, Arch Pathol Lab Med 2006 130 325 331 16519559
-
(2006)
Arch Pathol Lab Med
, vol.130
, pp. 325-331
-
-
Persons, D.L.1
Tubbs, R.R.2
Cooley, L.D.3
Dewald, G.W.4
Dowling, P.K.5
Du, E.6
Mascarello, J.T.7
Rao, K.W.8
Wilson, K.S.9
Wolff, D.J.10
Habegger-Vance, G.11
-
17
-
-
0038792812
-
Agreement between chromogenic in situ hybridization (CISH) and FISH in the determination of HER2 status in breast cancer
-
10.1038/sj.bjc.6600943. 12771927
-
Agreement between chromogenic in situ hybridization (CISH) and FISH in the determination of HER2 status in breast cancer. L Arnould Y Denoux G MacGrogan F Penault-Llorca M Fiche I Treilleux MC Mathieu A Vincent-Salomon MO Vilain J Couturier, Br J Cancer 2003 88 1587 1591 10.1038/sj.bjc.6600943 12771927
-
(2003)
Br J Cancer
, vol.88
, pp. 1587-1591
-
-
Arnould, L.1
Denoux, Y.2
MacGrogan, G.3
Penault-Llorca, F.4
Fiche, M.5
Treilleux, I.6
Mathieu, M.C.7
Vincent-Salomon, A.8
Vilain, M.O.9
Couturier, J.10
-
18
-
-
0036082527
-
Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma
-
10.1038/modpathol.3880582. 12065780
-
Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma. J Zhao R Wu A Au A Marquez Y Yu Z Shi, Mod Pathol 2002 15 657 665 10.1038/modpathol.3880582 12065780
-
(2002)
Mod Pathol
, vol.15
, pp. 657-665
-
-
Zhao, J.1
Wu, R.2
Au, A.3
Marquez, A.4
Yu, Y.5
Shi, Z.6
-
19
-
-
7444228551
-
Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization. Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and Ki-67 protein expression, and outcome
-
10.1038/modpathol.3800006
-
Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization. Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and Ki-67 protein expression, and outcome. G Peiró D Mayr P Hillemanns U Löhrs J Diebold, Mod Pathol 2004 17 277 287 10.1038/modpathol.3800006
-
(2004)
Mod Pathol
, vol.17
, pp. 277-287
-
-
Peiró, G.1
Mayr, D.2
Hillemanns, P.3
Löhrs, U.4
Diebold, J.5
-
20
-
-
0141853741
-
Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray
-
10.1097/01.MP.0000086487.78558.7D. 13679458
-
Comparing fluorescence in situ hybridization and chromogenic in situ hybridization methods to determine the HER2/neu status in primary breast carcinoma using tissue microarray. K Park J Kim S Lim S Han JY Lee, Mod Pathol 2003 16 937 943 10.1097/01.MP.0000086487.78558.7D 13679458
-
(2003)
Mod Pathol
, vol.16
, pp. 937-943
-
-
Park, K.1
Kim, J.2
Lim, S.3
Han, S.4
Lee, J.Y.5
-
21
-
-
33645298450
-
Chromogenic in-situ hybridization: A viable alternative to fluorescence in-situ hybridization in the HER2 testing algorithm
-
10.1038/modpathol.3800555. 16444193
-
Chromogenic in-situ hybridization: a viable alternative to fluorescence in-situ hybridization in the HER2 testing algorithm. WM Hanna K Kwok, Mod Pathol 2006 19 481 487 10.1038/modpathol.3800555 16444193
-
(2006)
Mod Pathol
, vol.19
, pp. 481-487
-
-
Hanna, W.M.1
Kwok, K.2
-
22
-
-
34247882706
-
Prognostic value of HER2 gene amplification detected by chromogenic in situ hybridization (CISH) in metastatic breast cancer
-
10.1016/j.yexmp.2007.01.002. 17335803
-
Prognostic value of HER2 gene amplification detected by chromogenic in situ hybridization (CISH) in metastatic breast cancer. N Todorović- Raković D Jovanović Z Nesković-Konstantinović D Nikolić-Vukosavljević Exp Mol Pathol 2007 82 262 268 10.1016/j.yexmp.2007.01.002 17335803
-
(2007)
Exp Mol Pathol
, vol.82
, pp. 262-268
-
-
Todorović-Raković, N.1
Jovanović, D.2
Nesković-Konstantinović, Z.3
Nikolić-Vukosavljević, D.4
-
23
-
-
0036094229
-
Gold facilitated in situ hybridization (GOLDFISH): A bright field autometallographic alternative to fluorescence in situ hybridization for detection of HER-2/neu gene amplification
-
Gold facilitated in situ hybridization (GOLDFISH): A bright field autometallographic alternative to fluorescence in situ hybridization for detection of HER-2/neu gene amplification. R Tubbs J Pettay M Skacel R Powell M Stoler P Roche J Hainfeld, Amer J Pathol 2002 160 1589 1595
-
(2002)
Amer J Pathol
, vol.160
, pp. 1589-1595
-
-
Tubbs, R.1
Pettay, J.2
Skacel, M.3
Powell, R.4
Stoler, M.5
Roche, P.6
Hainfeld, J.7
-
24
-
-
0036307977
-
Interobserver interpretative reproducibility of GOLDFISH, a first generation gold-facilitated autometallographic bright field in situ hybridization assay for HER-2/neu amplification in invasive mammary carcinoma
-
10.1097/00000478-200207000-00009. 12131158
-
Interobserver interpretative reproducibility of GOLDFISH, a first generation gold-facilitated autometallographic bright field in situ hybridization assay for HER-2/neu amplification in invasive mammary carcinoma. R Tubbs M Skacel J Pettay R Powell J Myles D Hicks J Sreenan P Roche MH Stoler J Hainfeld, Am J Surg Pathol 2002 26 908 913 10.1097/00000478-200207000-00009 12131158
-
(2002)
Am J Surg Pathol
, vol.26
, pp. 908-913
-
-
Tubbs, R.1
Skacel, M.2
Pettay, J.3
Powell, R.4
Myles, J.5
Hicks, D.6
Sreenan, J.7
Roche, P.8
Stoler, M.H.9
Hainfeld, J.10
-
25
-
-
16644396502
-
Novel bright field molecular morphology methods for detection of HER2 gene amplification
-
10.1007/s10735-004-2191-9. 15614612
-
Novel bright field molecular morphology methods for detection of HER2 gene amplification. R Tubbs J Pettay D Hicks M Skacel R Powell T Grogan J Hainfeld, J Mol Histol 2004 35 589 594 10.1007/s10735-004-2191-9 15614612
-
(2004)
J Mol Histol
, vol.35
, pp. 589-594
-
-
Tubbs, R.1
Pettay, J.2
Hicks, D.3
Skacel, M.4
Powell, R.5
Grogan, T.6
Hainfeld, J.7
-
26
-
-
27244440343
-
Analytical validation and interobserver reproducibility of EnzMet GenePro: A second-generation bright-field metallography assay for concomitant detection of HER2 gene status and protein expression in invasive carcinoma of the breast
-
10.1097/01.pas.0000172294.67409.4f. 16224218
-
Analytical validation and interobserver reproducibility of EnzMet GenePro: a second-generation bright-field metallography assay for concomitant detection of HER2 gene status and protein expression in invasive carcinoma of the breast. E Downs-Kelly J Pettay D Hicks M Skacel B Yoder L Rybicki J Myles J Sreenan P Roche R Powell J Hainfeld T Grogan R Tubbs, Am J Surg Pathol 2005 29 1505 1511 10.1097/01.pas.0000172294.67409.4f 16224218
-
(2005)
Am J Surg Pathol
, vol.29
, pp. 1505-1511
-
-
Downs-Kelly, E.1
Pettay, J.2
Hicks, D.3
Skacel, M.4
Yoder, B.5
Rybicki, L.6
Myles, J.7
Sreenan, J.8
Roche, P.9
Powell, R.10
Hainfeld, J.11
Grogan, T.12
Tubbs, R.13
-
27
-
-
34447312475
-
Metallographic in situ hybridization
-
10.1016/j.humpath.2007.05.004. 17640553
-
Metallographic in situ hybridization. RD Powell JD Pettay WC Powell PC Roche TM Grogan JF Hainfeld RR Tubbs, Hum Pathol 2007 38 1145 1159 10.1016/j.humpath.2007.05.004 17640553
-
(2007)
Hum Pathol
, vol.38
, pp. 1145-1159
-
-
Powell, R.D.1
Pettay, J.D.2
Powell, W.C.3
Roche, P.C.4
Grogan, T.M.5
Hainfeld, J.F.6
Tubbs, R.R.7
-
28
-
-
35748985896
-
Comparison of automated silver enhanced in situ hybridization (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of American Pathologists
-
10.1007/s00428-007-0424-5. 17562074
-
Comparison of automated silver enhanced in situ hybridization (SISH) and fluorescence ISH (FISH) for the validation of HER2 gene status in breast carcinoma according to the guidelines of the American Society of Clinical Oncology and the College of American Pathologists. M Dietel IO Ellis H Höfler H Kreipe H Moch A Dankof K Kölble G Kristiansen, Virchows Arch 2007 451 19 25 10.1007/s00428-007-0424-5 17562074
-
(2007)
Virchows Arch
, vol.451
, pp. 19-25
-
-
Dietel, M.1
Ellis, I.O.2
Höfler, H.3
Kreipe, H.4
Moch, H.5
Dankof, A.6
Kölble, K.7
Kristiansen, G.8
-
29
-
-
0036494110
-
Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers
-
11888924
-
Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers. TA Grushko MA Blackwood PL Schumm FG Hagos MO Adeyanju MD Feldman MO Sanders BL Weber OI Olopade, Cancer Res 2002 62 1481 1488 11888924
-
(2002)
Cancer Res
, vol.62
, pp. 1481-1488
-
-
Grushko, T.A.1
Blackwood, M.A.2
Schumm, P.L.3
Hagos, F.G.4
Adeyanju, M.O.5
Feldman, M.D.6
Sanders, M.O.7
Weber, B.L.8
Olopade, O.I.9
-
30
-
-
15544382365
-
Assessment of the HER2 Status in Breast Cancer by Fluorescence In-Situ Hybridization (FISH): A Technical Review with Interpretative Guidelines
-
10.1016/j.humpath.2004.11.010. 15791569
-
Assessment of the HER2 Status in Breast Cancer by Fluorescence In-Situ Hybridization (FISH): a Technical Review with Interpretative Guidelines. DG Hicks RR Tubbs, Hum Pathol 2005 36 250 261 10.1016/j.humpath.2004.11.010 15791569
-
(2005)
Hum Pathol
, vol.36
, pp. 250-261
-
-
Hicks, D.G.1
Tubbs, R.R.2
-
31
-
-
0037023986
-
Real-world performance of HER2 testing-National Surgical Adjuvant Breast and Bowel Project experience
-
12048273
-
Real-world performance of HER2 testing-National Surgical Adjuvant Breast and Bowel Project experience. S Paik J Bryant E Tan-Chiu E Romond W Hiller K Park A Brown G Yothers S Anderson R Smith DL Wickerham N Wolmark, J Natl Cancer Inst 2002 94 852 854 12048273
-
(2002)
J Natl Cancer Inst
, vol.94
, pp. 852-854
-
-
Paik, S.1
Bryant, J.2
Tan-Chiu, E.3
Romond, E.4
Hiller, W.5
Park, K.6
Brown, A.7
Yothers, G.8
Anderson, S.9
Smith, R.10
Wickerham, D.L.11
Wolmark, N.12
-
32
-
-
0037024478
-
Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831
-
12048274
-
Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831. PC Roche VJ Suman RB Jenkins NE Davidson S Martino PA Kaufman FK Addo B Murphy JN Ingle EA Perez, J Natl Cancer Inst 2002 94 11 855 857 12048274
-
(2002)
J Natl Cancer Inst
, vol.94
, Issue.11
, pp. 855-857
-
-
Roche, P.C.1
Suman, V.J.2
Jenkins, R.B.3
Davidson, N.E.4
Martino, S.5
Kaufman, P.A.6
Addo, F.K.7
Murphy, B.8
Ingle, J.N.9
Perez, E.A.10
-
33
-
-
34250811980
-
HER2 testing in the UK: Consensus from a national consultation
-
National HER2 Consultation Steering Group, 10.1136/jcp.2006.044321. 17322344
-
HER2 testing in the UK: consensus from a national consultation. M Dowsett AM Hanby R Laing R Walker National HER2 Consultation Steering Group, J Clin Pathol 2007 60 685 689 10.1136/jcp.2006.044321 17322344
-
(2007)
J Clin Pathol
, vol.60
, pp. 685-689
-
-
Dowsett, M.1
Hanby, A.M.2
Laing, R.3
Walker, R.4
-
34
-
-
34249822213
-
Standardizing slide-based assays in breast cancer: Hormone receptors, HER2, and sentinel lymph nodes
-
10.1158/1078-0432.CCR-06-2522. 17504980
-
Standardizing slide-based assays in breast cancer: hormone receptors, HER2, and sentinel lymph nodes. JS Ross WF Symmans L Pusztai GN Hortobagyi, Clin Cancer Res 2007 13 2831 2835 10.1158/1078-0432.CCR-06-2522 17504980
-
(2007)
Clin Cancer Res
, vol.13
, pp. 2831-2835
-
-
Ross, J.S.1
Symmans, W.F.2
Pusztai, L.3
Hortobagyi, G.N.4
-
35
-
-
49149104382
-
Undated recommendation from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer
-
17710207. 10.3747/co.2007.131
-
Undated recommendation from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer. W Hanna FP O'malley P Barnes R Berendt L Gaboury A Magliocco N Pettigrew S Robertson S Sengupta B Têtu T Thomson, Curr Oncol 2007 14 149 153 17710207 10.3747/co.2007.131
-
(2007)
Curr Oncol
, vol.14
, pp. 149-153
-
-
Hanna, W.1
O'Malley, F.P.2
Barnes, P.3
Berendt, R.4
Gaboury, L.5
Magliocco, A.6
Pettigrew, N.7
Robertson, S.8
Sengupta, S.9
Têtu, B.10
Thomson, T.11
-
36
-
-
33751382730
-
Automation of manual components and image quantification of direct dual label fluorescence in situ hybridization (FISH) for HER2 gene amplification: A feasibility study
-
10.1097/01.pai.0000213101.26193.f1. 17122642
-
Automation of manual components and image quantification of direct dual label fluorescence in situ hybridization (FISH) for HER2 gene amplification: a feasibility study. RR Tubbs JD Pettay E Swain PC Roche W Powell DG Hicks T Grogan, Appl Immunohistochem Mol Morphol 2006 14 436 440 10.1097/01.pai. 0000213101.26193.f1 17122642
-
(2006)
Appl Immunohistochem Mol Morphol
, vol.14
, pp. 436-440
-
-
Tubbs, R.R.1
Pettay, J.D.2
Swain, E.3
Roche, P.C.4
Powell, W.5
Hicks, D.G.6
Grogan, T.7
-
37
-
-
33745346284
-
HER-2 status in breast cancer: Correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system
-
10.1097/01.pai.0000150516.75567.13. 16785779
-
HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system. A Ciampa B Xu G Ayata D Baiyee J Wallace M Wertheimer K Edmiston A Khan, Appl Immunohistochem Mol Morphol 2006 14 132 137 10.1097/01.pai.0000150516.75567.13 16785779
-
(2006)
Appl Immunohistochem Mol Morphol
, vol.14
, pp. 132-137
-
-
Ciampa, A.1
Xu, B.2
Ayata, G.3
Baiyee, D.4
Wallace, J.5
Wertheimer, M.6
Edmiston, K.7
Khan, A.8
-
38
-
-
38949166886
-
Evaluation of FISH image analysis system on assessing HER2 amplification in breast carcinoma cases
-
10.1016/j.breast.2007.07.041. 17889539
-
Evaluation of FISH image analysis system on assessing HER2 amplification in breast carcinoma cases. Z Theodosiou IN Kasampalidis G Karayannopoulou I Kostopoulos M Bobos G Bevilacqua P Aretini A Starita K Lyroudia I Pitas, Breast 2007 17 80 84 10.1016/j.breast.2007.07.041 17889539
-
(2007)
Breast
, vol.17
, pp. 80-84
-
-
Theodosiou, Z.1
Kasampalidis, I.N.2
Karayannopoulou, G.3
Kostopoulos, I.4
Bobos, M.5
Bevilacqua, G.6
Aretini, P.7
Starita, A.8
Lyroudia, K.9
Pitas, I.10
-
39
-
-
34247843057
-
Analysis of HER2 gene amplification using an automated fluorescence in situ hybridization signal enumeration system
-
17384205. 10.2353/jmoldx.2007.060102
-
Analysis of HER2 gene amplification using an automated fluorescence in situ hybridization signal enumeration system. R Stevens I Almanaseer M Gonzalez D Caglar RA Knudson RP Ketterling DS Schrock TA Seemayer JA Bridge, J Mol Diagn 2007 9 144 150 17384205 10.2353/jmoldx.2007.060102
-
(2007)
J Mol Diagn
, vol.9
, pp. 144-150
-
-
Stevens, R.1
Almanaseer, I.2
Gonzalez, M.3
Caglar, D.4
Knudson, R.A.5
Ketterling, R.P.6
Schrock, D.S.7
Seemayer, T.A.8
Bridge, J.A.9
-
40
-
-
0028067041
-
A novel triple-color detection procedure for brightfield microscopy, combining in situ hybridization with immunocytochemistry
-
7930513
-
A novel triple-color detection procedure for brightfield microscopy, combining in situ hybridization with immunocytochemistry. EJ Speel MP Jansen FC Ramaekers AH Hopman, J Histochem Cytochem 1994 42 1299 1307 7930513
-
(1994)
J Histochem Cytochem
, vol.42
, pp. 1299-1307
-
-
Speel, E.J.1
Jansen, M.P.2
Ramaekers, F.C.3
Hopman, A.H.4
-
41
-
-
0030779625
-
Multi-colour brightfield in situ hybridization on tissue sections
-
10.1007/s004180050168. 9387920
-
Multi-colour brightfield in situ hybridization on tissue sections. AHN Hopman S Claessen EJM Speel, Histochem Cell Biol 1997 108 291 298 10.1007/s004180050168 9387920
-
(1997)
Histochem Cell Biol
, vol.108
, pp. 291-298
-
-
Hopman, A.H.N.1
Claessen, S.2
Speel, E.J.M.3
-
42
-
-
33747883996
-
Dual-colour chromogenic in situ hybridization for testing HER-2 oncogene amplification in archival breast tumors
-
10.1002/path.2022. 16823892
-
Dual-colour chromogenic in situ hybridization for testing HER-2 oncogene amplification in archival breast tumors. M Laakso M Tanner J Isola, J Pathol 2006 210 3 9 10.1002/path.2022 16823892
-
(2006)
J Pathol
, vol.210
, pp. 3-9
-
-
Laakso, M.1
Tanner, M.2
Isola, J.3
-
43
-
-
36649015630
-
Fluorescence in situ hybridization (FISH) as primary methodology for the assessment of HER2 status in adenocarcinoma of the breast
-
18043283
-
Fluorescence in situ hybridization (FISH) as primary methodology for the assessment of HER2 status in adenocarcinoma of the breast. RR Tubbs DG Hicks J Cook E Downs-Kelly J Pettay MB Hartke L Hood R Neelon J Myles GT Budd HC Moore S Andresen JP Crowe, Diagn Mol Pathol 2007 16 207 210 18043283
-
(2007)
Diagn Mol Pathol
, vol.16
, pp. 207-210
-
-
Tubbs, R.R.1
Hicks, D.G.2
Cook, J.3
Downs-Kelly, E.4
Pettay, J.5
Hartke, M.B.6
Hood, L.7
Neelon, R.8
Myles, J.9
Budd, G.T.10
Moore, H.C.11
Andresen, S.12
Crowe, J.P.13
-
44
-
-
34548017672
-
Inconsistency of HER2 test raises questions
-
10.1093/jnci/djm075. 17623788
-
Inconsistency of HER2 test raises questions. RS Tuma, J Natl Cancer Inst 2007 99 1064 1065 10.1093/jnci/djm075 17623788
-
(2007)
J Natl Cancer Inst
, vol.99
, pp. 1064-1065
-
-
Tuma, R.S.1
|